Role of Endothelin and Isoprostanes in Slow Pressor Responses to Angiotensin II
- 1 February 2001
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 37 (2) , 505-510
- https://doi.org/10.1161/01.hyp.37.2.505
Abstract
We tested the hypothesis that angiotensin II (Ang II)–induced stimulations of endothelin (ET) and isoprostanes are implicated in the slow pressor responses to Ang II. We infused either vehicle (gro...Keywords
This publication has 13 references indexed in Scilit:
- Subpressor Doses of Angiotensin II Increase Plasma F 2 -Isoprostanes in RatsHypertension, 2000
- Low-Dose Angiotensin II Increases Free Isoprostane Levels in PlasmaHypertension, 1999
- Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin RegulationBiochemical and Biophysical Research Communications, 1997
- The isoprostanes: Unique bioactive products of lipid peroxidationProgress in Lipid Research, 1997
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- Stimulatory Effect of 8-Epi-PGF2α, An F2-Isoprostane, on Endothelin-1 ReleaseJournal of Cardiovascular Pharmacology, 1995
- Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.Proceedings of the National Academy of Sciences, 1992
- Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.Journal of Clinical Investigation, 1992
- Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.Hypertension, 1992
- Cellular mechanism of endothelin-1 release by angiotensin and vasopressin.Hypertension, 1991